UCB Japan to Independently Market New Products; Stand-Alone E Keppra Sales “Going Smoothly”: President

UCB Japan President Kanako Kikuchi UCB Japan’s independent marketing of the anti-epilepsy drug E Keppra (levetiracetam), which was initiated from October, “is going smoothly,” President Kanako Kikuchi told Jiho in a recent interview. The company plans stand-alone sales for future...read more